Skip to main content

Cookies on the NHS England website

We’ve put some small files called cookies on your device to make our site work.

We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.

Let us know if this is OK. We’ll use a cookie to save your choice. You canĀ read more about our cookies before you choose.

 

Your feedback matters and will make a difference. Help us understand your digital experience by taking our 10 minute survey. Your responses are completely anonymous. Start the survey.

  • Home
  • News
  • Publications
  • Statistics
  • Blogs
  • Events
  • Contact us
NHS England
  • About us
  • Our work
  • Commissioning
  • Get involved

Clinical commissioning policy: Allogeneic haematopoietic stem cell transplant for patients with X-linked cerebral adrenoleukodystrophy (adults)

Document first published:
6 November 2023
Page updated:
6 November 2023
Topic:
Specialised commissioning
Publication type:
Policy or strategy

Allo-HSCT is recommended to be available as a routinely commissioned treatment option for adult patients with C-ALD in within the criteria set out in this document.

Document

Clinical commissioning policy: Allogeneic haematopoietic stem cell transplant for patients with X-linked cerebral adrenoleukodystrophy (adults)

Clinical commissioning policy: Allogeneic haematopoietic stem cell transplant for patients with X-linked cerebral adrenoleukodystrophy (adults)

  • PDF
  • 211 KB
  • 7 pages

Document

Clinical priorities advisory group report: Allogeneic haematopoietic stem cell transplant for patients with X-linked cerebral adrenoleukodystrophy (adults)

Clinical priorities advisory group report: Allogeneic haematopoietic stem cell transplant for patients with X-linked cerebral adrenoleukodystrophy (adults)

  • PDF
  • 227 KB
  • 19 pages

Document

Clinical panel report: Allogeneic haematopoietic stem cell transplant for patients with X-linked cerebral adrenoleukodystrophy (adults)

Clinical panel report: Allogeneic haematopoietic stem cell transplant for patients with X-linked cerebral adrenoleukodystrophy (adults)

  • PDF
  • 110 KB
  • 2 pages

Document

Engagement report: Allogeneic haematopoietic stem cell transplant for patients with X-linked cerebral adrenoleukodystrophy (adults)

Engagement report: Allogeneic haematopoietic stem cell transplant for patients with X-linked cerebral adrenoleukodystrophy (adults)

  • PDF
  • 109 KB
  • 3 pages

Document

Evidence review: Allogeneic haematopoietic stem cell transplant for patients with X-linked cerebral adrenoleukodystrophy (adults)

Evidence review: Allogeneic haematopoietic stem cell transplant for patients with X-linked cerebral adrenoleukodystrophy (adults)

  • PDF
  • 611 KB
  • 76 pages

Document

Equality and Health Inequalities Impact Assessment (EHIA): Allogeneic haematopoietic stem cell transplant for patients with X-linked cerebral adrenoleukodystrophy (adults)

Equality and Health Inequalities Impact Assessment (EHIA): Allogeneic haematopoietic stem cell transplant for patients with X-linked cerebral adrenoleukodystrophy (adults)

  • PDF
  • 119 KB
  • 11 pages
  • Terms and conditions
  • Privacy and cookies
  • Social media moderation
  • Website feedback
  • Accessibility statement
  • Open Government Licence v3.0
  • Sign up to our email bulletins
  • Follow us on X
  • Follow us on Facebook
  • Find us on Instagram
  • Visit us on LinkedIn
  • Watch videos on YouTube
NHS website